DDP ip Combined With AG in PDAC With Peritoneal Metastasis

NCT05222204 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

91

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Neoplasm

Interventions

DRUG: intraperitoneal (IP) Cisplatin combined with intravenous gemcitabine + nab-paclitaxel

Sponsor

Fudan University